The Patient-Reported Outcome (PRO) Consortium Lessons Learned Along the Path to PRO Instrument Qualification
PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force
January 7, 2014 Coalition Against Major Diseases/European Medicines Agency Biomarker Qualification Of Hippocampal Volume For Enrichment Of Clinical Trials In Predementia Stages Of Alzheimer’s Disease
Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research, on FDA’s Critical Path Initiative
Identifying and Measuring the Core Symptoms Reported by Persons with Asthma: A review of the Existing Qualitative Literature and Patient-Reported Outcome Measures
